Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue66¢$14.4M
- Other costs4¢$884.0K
- Interest29¢$6.4M
- Income tax0¢$13.2K
Out of $21.8M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.4M4 | $4.9M5 | $8.1M6 | $21.9M3 | $21.8M3 | ||
| Cost of revenue | $1.0M4 | $2.6M5 | $4.8M6 | $13.3M3 | $14.4M3 | ||
| Gross profit | $383.7K4 | $2.4M5 | $3.3M6 | $8.6M3 | $7.3M3 | ||
| Research and development | |||||||
| Operating expenses | $30.4M3 | ||||||
| Operating income | -$653.8K4 | -$10.1M5 | -$5.4M6 | -$5.6M3 | -$23.1M3 | ||
| Interest | $1.6K4 | $342.7K5 | $7.0M6 | $5.3M3 | $6.4M3 | ||
| Income tax | $88.8K4 | -$86.0K6 | $13.2K3 | ||||
| Net income | -$688.7K4 | -$9.9M5 | -$12.3M6 | -$10.9M3 | -$31.2M3 | ||
| Earnings per share | -$0.143 | -$0.333 | |||||
| Earnings per share (diluted) | -$0.143 | -$0.333 | |||||
| Shares (weighted, basic) | 95.7M shares3 |
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $13.9K4 | $1.7M5 | $574.9K6 | $84.7K3 | $1.5M3 | $85.6K3 | |
| Receivables | $586.3K3 | ||||||
| Inventory | $2.5M3 | ||||||
| Current assets | $3.3M4 | $3.0M5 | $2.9M6 | $10.1M3 | $3.6M3 | ||
| Property, plant and equipment | $21.0M3 | ||||||
| Goodwill | $58.2M3 | ||||||
| Intangible assets | $11.7M3 | ||||||
| Total assets | $5.0M4 | $14.5M5 | $20.7M6 | $116.8M3 | $110.8M3 | ||
| Accounts payable | $6.4M3 | ||||||
| Current liabilities | $981.2K4 | $7.1M5 | $10.3M6 | $15.0M3 | $40.6M3 | ||
| Long-term debt | $1.5M4 | $2.2M6 | $15.0M3 | $7.2M3 | |||
| Total liabilities | $2.5M4 | $7.1M5 | $12.6M6 | $30.7M3 | $48.8M3 | ||
| Retained earnings | -$65.0M3 | ||||||
| Shareholders’ equity | $968.6K4 | $2.6M4 | $7.3M6 | $8.0M6 | $86.1M3 | $62.0M3 | |
| Shares outstanding | 74.4M shares9 | 54.8M shares4 | 63.6M shares5 | 56.0M shares6 | 94.8M shares3 | 97.7M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$972.3K4 | -$2.4M5 | -$1.1M6 | -$6.0M3 | -$2.3M3 | ||
| Depreciation and amortization | $1.6M3 | ||||||
| Stock-based compensation | $3.0M3 | ||||||
| Capital spending | $340.2K4 | $6.0M5 | $167.2K6 | $2.2M3 | $4.3M3 | ||
| Free cash flow | -$1.3M | -$8.4M | -$1.3M | -$8.2M | -$6.6M | ||
| Cash from investing | -$5.2M3 | ||||||
| Cash from financing | $6.0M3 |
Corporate structure
Item 9 Labs Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Item 9 Labs Corp.
- Clearthink Capital Partners, LLC Filed SC 13G on Item 9 Labs Corp., latest Feb 21, 2024
- Item 9 Labs Corp. Phoenix, Arizona
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Item 9 Labs Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Land | $3.5M3 Sep 30, 2022 | $380.6K3 Sep 30, 2021 | +808.0% |
| Construction in progress | $9.6M3 Sep 30, 2022 | ||
| Property and equipment, before depreciation | $3.6M6 Sep 30, 2021 | $2.9M6 Sep 30, 2020 | +23.5% |
| Accumulated depreciation | $777.5K3 Sep 30, 2022 | $479.3K3 Sep 30, 2021 | +62.2% |
| Property and equipment, net | $21.0M3 Sep 30, 2022 | $10.9M3 Sep 30, 2021 | +93.2% |
| Operating-lease assets (leased space) | $938.7K3 Sep 30, 2022 | $156.9K3 Sep 30, 2021 | +498.1% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $58.2M3 Sep 30, 2022 | $58.1M3 Sep 30, 2021 | +0.3% |
| Intangible assets, net (excluding goodwill) | $11.7M3 Sep 30, 2022 | $18.7M3 Sep 30, 2021 | −37.1% |
| Licenses, net | $6.7M3 Sep 30, 2022 |
Inventory
Leadership
Who has led Item 9 Labs Corp., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerSara Gullickson Aug 28, 2019 to Aug 28, 201910
- Chief executive officerFamily Limited Partnership Hayjour Jul 25, 2013 to Nov 16, 201611
- ChairFamily Limited Partnership Hayjour Aug 28, 2019 to Aug 28, 201912
- PresidentBryce Skalla Aug 29, 2019 to Sep 11, 201913
- PresidentDaniel E. Cohen Md. Nov 15, 2016 to Nov 15, 201614
- PresidentFamily Limited Partnership Hayjour Jul 25, 2013 to Nov 24, 201411
- Chief financial officerRobert E. Mikkelsen Aug 28, 2019 to Aug 28, 201915
- Chief financial officerJessica L. Smith Jan 16, 2014 to Nov 15, 201616
- Chief operating officerChristopher Leland Wolven Aug 28, 2019 to Aug 28, 201917
- Chief operating officerLorrie Henderson Jan 22, 2014 to Jan 22, 201418
Board members and other officers (9)
- Board memberEric Kutscher Jan 10, 2022 to Jan 10, 202219
- Board memberLawrence X. Taylor Iii. Jan 10, 2022 to Jan 10, 202220
- Board memberDouglas P. Bowden Apr 5, 2021 to Apr 5, 202121
- Board memberMichael P. Keskey Aug 13, 2020 to Aug 13, 202022
- Board memberAndrew Douglas Bowden Aug 28, 2019 to Aug 28, 201923
- Board memberSara Gullickson Aug 28, 2019 to Aug 28, 201910
- Board memberBryce Skalla Aug 29, 2019 to Sep 11, 201913
- Board memberDaniel E. Cohen Md. Nov 15, 2016 to Nov 15, 201614
- Board memberFamily Limited Partnership Hayjour Jul 25, 2013 to Nov 16, 201611
Former names
Timeline
- Jul 20, 20238-K Bankruptcy or receivership; Executive or director change24
- Jul 7, 20238-K Executive or director change25
- Jun 27, 20238-K Executive or director change26
- Jun 6, 20238-K Ended a material agreement27
- May 22, 20238-K Executive or director change; Other events28
- May 12, 20238-K Executive or director change29
- May 5, 20238-K Entered a material agreement; New debt or obligation; Unregistered sale of shares30
- Apr 5, 20238-K Debt or obligation accelerated31
- Mar 10, 20238-K Debt or obligation accelerated32
- Nov 30, 20228-K Unregistered sale of shares; Executive or director change; Regulation FD disclosure33
- Oct 11, 20228-K Unregistered sale of shares34
- Aug 16, 20228-K Regulation FD disclosure35
- Aug 28, 2019New chief executive Sara Gullickson becomes CEO10
- Jul 25, 2013New chief executive Family Limited Partnership Hayjour becomes CEO11
Filings
46 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 25 major events, 2 insider forms, 1 large holders, 10 other. The latest 20:
- Feb 21, 2024SC 13G SCHEDULE 13G EDGAR
- Aug 21, 202310-Q EDGAR
- Aug 14, 2023NT 10-Q FORM 12B-25 EDGAR
- Jul 20, 20238-K EDGAR
- Jul 7, 20238-K EDGAR
- Jun 27, 20238-K EDGAR
- Jun 6, 20238-K EDGAR
- May 22, 202310-Q EDGAR
- May 22, 20238-K EDGAR
- May 15, 2023NT 10-Q FORM 12B-25 EDGAR
- May 12, 20238-K EDGAR
- May 5, 20238-K EDGAR
- Apr 5, 20238-K EDGAR
- Mar 10, 20238-K EDGAR
- Feb 14, 202310-Q EDGAR
- Jan 13, 202310-K EDGAR
- Dec 29, 2022NT 10-K FORM 12B-25 EDGAR
- Nov 30, 20228-K EDGAR
- Oct 11, 20228-K EDGAR
- Aug 16, 20228-K EDGAR
The 46 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Clearthink Capital Partners, LLCSC 13G, 1 filing Feb 21, 202436
SEC filer profile
How Item 9 Labs Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARItem 9 Labs Corp.1
- CIK0001500123
- Employer ID (EIN)98-06650181
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inDelaware1
- Fiscal year endsSeptember 301
- Industry code (SIC)3843 Dental Equipment & Supplies1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address2111 E Highland Ave, Suite B375, Phoenix, AZ 850161
- Phone833-867-63371
- Shares outstanding102,362,271 as of Aug 21, 20238
- Public float$117.9M as of Mar 31, 20223
- On EDGAR sinceSep 21, 20101
- Filings248 in all: 8-K (70), 10-Q (27), UPLOAD (26), CORRESP (18), 3 (15), 5 (13), NT 10-Q (10), 10-K (9)1
All 33 form types
NT 10-K (8), 8-K/A (7), S-1/A (7), 10-Q/A (5), 4 (5), D (5), PRER14C (3), 8-K12G3/A (2), D/A (2), 1-A (1), 1-A/A (1), 10-12G (1), 10-12G/A (1), 10-K/A (1), 10-QT (1), 15-12G (1), 253G2 (1), 5/A (1), 8-K12G3 (1), DEF 14C (1), EFFECT (1), PRE 14C (1), QUALIF (1), S-1 (1), SC 13G (1)
- Latest filingsAnnual report (10-K) Jan 13, 2023
Quarterly report (10-Q) Aug 21, 2023
Latest 8-K (8-K) Jul 20, 2023
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARBryce Skalla, President
- 14SEC EDGARDaniel E. Cohen Md., President
- 15
- 16
- 17
- 18
- 19SEC EDGAREric Kutscher, Board member
- 20
- 21SEC EDGARDouglas P. Bowden, Board member
- 22SEC EDGARMichael P. Keskey, Board member
- 23SEC EDGARAndrew Douglas Bowden, Board member
- 24
- 25SEC EDGARExecutive or director change
- 26SEC EDGARExecutive or director change
- 27SEC EDGAREnded a material agreement
- 28
- 29SEC EDGARExecutive or director change
- 30
- 31SEC EDGARDebt or obligation accelerated
- 32SEC EDGARDebt or obligation accelerated
- 33
- 34SEC EDGARUnregistered sale of shares
- 35SEC EDGARRegulation FD disclosure
- 36